Potential Drug Target Or Biomarker: RBM41, A RNA-Binding Protein

Target Name: RBM41

NCBI ID: G55285

RBM41

Potential Drug Target Or Biomarker: RBM41, A RNA-Binding Protein

RNA-binding protein 41 (RBM41) is a protein that is expressed in various tissues and cells of the human body. It plays a critical role in the regulation of gene expression and has been associated with various diseases, including cancer.

RBM41 is a 22-kDa protein that is expressed in the brain, heart, liver, and other tissues. It is composed of a 165 amino acid chain and has a calculated molecular mass of 19.9 kDa. RBM41 is predominantly expressed in the brain, with a relatively low expression level in the heart and other tissues.

The function of RBM41 is still not well understood, but it is known to play a role in the regulation of gene expression and cell signaling. RBM41 has been shown to interact with various proteins, including transcription factors, and has been shown to regulate the expression of target genes.

One of the most interesting aspects of RBM41 is its potential as a drug target or biomarker. RBM41 has been shown to play a role in the regulation of cancer cell growth and has been shown to be involved in the development of various types of cancer, including breast, ovarian, and prostate cancer.

In addition to its potential as a drug target, RBM41 has also been shown to be a potential biomarker for various types of cancer. RBM41 has been shown to be expressed in various types of cancer and has been shown to be involved in the regulation of cancer cell growth and progression.

Overall, RBM41 is a protein that is of great interest to researchers as a potential drug target or biomarker. Further research is needed to fully understand its function and its potential as a drug.

Protein Name: RNA Binding Motif Protein 41

Functions: May bind RNA

The "RBM41 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RBM41 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets